Literature DB >> 26059472

MicroRNA: master controllers of intracellular signaling pathways.

Pak-Yin Lui1, Dong-Yan Jin, Nigel J Stevenson.   

Abstract

Signaling pathways are essential intracellular networks that coordinate molecular outcomes to external stimuli. Tight regulation of these pathways is essential to ensure an appropriate response. MicroRNA (miRNA) is a class of small, non-coding RNA that regulates gene expression at a post-transcriptional level by binding to the complementary sequence on target mRNA, thus limiting protein translation. Intracellular pathways are controlled by protein regulators, such as suppressor of cytokine signaling and A20. Until recently, expression of these classical protein regulators was thought to be controlled solely by transcriptional induction and proteasomal degradation; however, there is a growing body of evidence describing their regulation by miRNA. This new information has transformed our understanding of cell signaling by adding a previously unknown layer of regulatory control. This review outlines the miRNA regulation of these classical protein regulators and describes their broad effects at both cellular and disease levels. We review the regulation of three important signaling pathways, including the JAK/STAT, NF-κB, and TGF-β pathways, and summarize an extensive catalog of their regulating miRNAs. This information highlights the importance of the miRNA regulon and reveals a previously unknown regulatory landscape that must be included in the identification and development of novel therapeutic targets for clinical disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26059472     DOI: 10.1007/s00018-015-1940-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  102 in total

1.  Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.

Authors:  Jen-Liang Su; Poshen B Chen; Ya-Huey Chen; Shang-Chih Chen; Yi-Wen Chang; Yi-Hua Jan; Xiaoyun Cheng; Michael Hsiao; Mien-Chie Hung
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells.

Authors:  Daisuke Takiuchi; Hidetoshi Eguchi; Hiroaki Nagano; Yoshifumi Iwagami; Yoshito Tomimaru; Hiroshi Wada; Koichi Kawamoto; Shogo Kobayashi; Shigeru Marubashi; Masahiro Tanemura; Masaki Mori; Yuichiro Doki
Journal:  Pancreatology       Date:  2013-06-28       Impact factor: 3.996

3.  MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20).

Authors:  Sang-Woo Kim; Kumaraguruparan Ramasamy; Hakim Bouamar; An-Ping Lin; Daifeng Jiang; Ricardo C T Aguiar
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

4.  Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells.

Authors:  Catherine E Moffatt; Richard J Lamont
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

Review 5.  Regulation of NF-κB by ubiquitination.

Authors:  Jueqi Chen; Zhijian J Chen
Journal:  Curr Opin Immunol       Date:  2013-01-08       Impact factor: 7.486

6.  Human TRBP and PACT directly interact with each other and associate with dicer to facilitate the production of small interfering RNA.

Authors:  Kin Hang Kok; Ming-Him James Ng; Yick-Pang Ching; Dong-Yan Jin
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

Review 7.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

8.  A miR-19 regulon that controls NF-κB signaling.

Authors:  Michael P Gantier; H James Stunden; Claire E McCoy; Mark A Behlke; Die Wang; Maria Kaparakis-Liaskos; Soroush T Sarvestani; Yuan H Yang; Dakang Xu; Sinéad C Corr; Eric F Morand; Bryan R G Williams
Journal:  Nucleic Acids Res       Date:  2012-06-07       Impact factor: 16.971

9.  MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation.

Authors:  Qiong Li; Daoxiang Zhang; Yongbin Wang; Pan Sun; Xiaodan Hou; James Larner; Wujun Xiong; Jun Mi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.

Authors:  W Wu; M Takanashi; N Borjigin; S-i Ohno; K Fujita; S Hoshino; Y Osaka; A Tsuchida; M Kuroda
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

View more
  17 in total

Review 1.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

Review 2.  The Dark Side of Cell Signaling: Positive Roles for Negative Regulators.

Authors:  Mark A Lemmon; Daniel M Freed; Joseph Schlessinger; Anatoly Kiyatkin
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

Review 3.  A step-by-step microRNA guide to cancer development and metastasis.

Authors:  Georgios S Markopoulos; Eugenia Roupakia; Maria Tokamani; Evangelia Chavdoula; Maria Hatziapostolou; Christos Polytarchou; Kenneth B Marcu; Athanasios G Papavassiliou; Raphael Sandaltzopoulos; Evangelos Kolettas
Journal:  Cell Oncol (Dordr)       Date:  2017-07-26       Impact factor: 6.730

4.  miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1.

Authors:  Bin Zhang; Sheqing Ji; Fei Ma; Qi Ma; Xianzhi Lu; Xiaobing Chen
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

5.  MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins.

Authors:  Lidia Avalle; Danny Incarnato; Aurora Savino; Marta Gai; Francesca Marino; Sara Pensa; Isaia Barbieri; Michael B Stadler; Paolo Provero; Salvatore Oliviero; Valeria Poli
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

6.  MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.

Authors:  Feng Liu; Linfeng Wu; Anping Wang; Yajun Xu; Xiaodong Luo; Xing Liu; Yi Hua; Deying Zhang; Shengde Wu; Tao Lin; Dawei He; Guanghui Wei; Shanwen Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 7.  The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Aleš Goropevšek; Marija Holcar; Tadej Avčin
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

8.  S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling.

Authors:  Carolin Lerchenmüller; Julian Heißenberg; Federico Damilano; Vassilios J Bezzeridis; Isabel Krämer; Marie-Luce Bochaton-Piallat; Kristóf Hirschberg; Martin Busch; Hugo A Katus; Karsten Peppel; Anthony Rosenzweig; Hauke Busch; Melanie Boerries; Patrick Most
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-07       Impact factor: 8.311

Review 9.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

Review 10.  MicroRNAs: Potential Biomarkers and Therapeutic Targets for Alveolar Bone Loss in Periodontal Disease.

Authors:  Tadayoshi Kagiya
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.